Greg Winter

Sir Gregory Paul Winter CBE FRS FMedSci (born 14 April 1951) is a British biochemist. He is best known for his work on the therapeutic use of monoclonal antibodies. He invented techniques to both humanise (1986) and, later, to fully humanise using phage display, antibodies for therapeutic uses.^[5]

Sir Greg Winter CBE FRS FMedSci
Gregory Winter in December 2018
Born	(1951-04-14) 14 April 1951 (age 74)[1] Leicester, Leicestershire, U.K.
Education	Royal Grammar School, Newcastle upon Tyne
Alma mater	University of Cambridge (MA, PhD)
Known for	Cambridge Antibody Technology Domantis Bicycle Therapeutics Antibody engineering
Awards	Colworth Medal (1986) EMBO Member (1987)[2] Louis-Jeantet Prize for Medicine (1989) Knight Bachelor (2004) Royal Medal (2011) Prince Mahidol Award (2016)[3] Nobel Prize in Chemistry (2018)[4]
Scientific career
Fields	Biochemistry
Institutions	University of Cambridge Laboratory of Molecular Biology
Thesis	The amino acid sequence of tryptophanyl tRNA synthetase from Bacillus stearothermophilus (1977)
Doctoral advisor	Brian S. Hartley George Brownlee
Website	trin.cam.ac.uk/about/master-fellows/master/winter/

Winter won the 2018 Nobel Prize in Chemistry along with George P. Smith and Frances Arnold.^[6]